Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


18.03.2019

2 Am J Cardiol
3 Atherosclerosis
1 Biochem Biophys Res Commun
1 BMJ
1 Diabet Med
2 Diabetes
10 Diabetes Care
1 Diabetes Educ
6 Diabetes Obes Metab
2 Diabetologia
2 J Am Soc Nephrol
1 J Clin Endocrinol Metab
2 J Diabetes Complications
3 JAMA
4 Lancet
5 Lancet Diabetes Endocrinol
1 Metabolism
1 Nutr Metab (Lond)
3 Pediatr Diabetes
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. KURIHARA O, Thondapu V, Kim HO, Russo M, et al
    Comparison of Vascular Response to Statin Therapy in Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2019 Feb 22. pii: S0002-9149(19)30225.
    PubMed     Text format     Abstract available

  2. SMIT JM, El Mahdiui M, van Rosendael AR, Jukema JW, et al
    Comparison of Diagnostic Performance of Quantitative Flow Ratio in Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2019 Feb 22. pii: S0002-9149(19)30241.
    PubMed     Text format     Abstract available


    Atherosclerosis

  3. HAGENSEN MK, Mortensen MB, Kjolby M, Palmfeldt J, et al
    Increased retention of LDL from type 1 diabetic patients in atherosclerosis-prone areas of the murine arterial wall.
    Atherosclerosis. 2019 Mar 4. pii: S0021-9150(19)30114.
    PubMed     Text format     Abstract available

  4. KOWALL B, Erbel R, Moebus S, Lehmann N, et al
    Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study.
    Atherosclerosis. 2019;284:37-43.
    PubMed     Text format     Abstract available

  5. SCHERNTHANER GH, Rami-Merhar B, Zierfuss B
    Gestational diabetes and maternal obesity suggestively priming children's premature atherosclerosis: Is it the mother fault?
    Atherosclerosis. 2019 Mar 4. pii: S0021-9150(19)30115.
    PubMed     Text format    


    Biochem Biophys Res Commun

  6. GAO T, Qian S, Shen S, Zhang X, et al
    Reduction of mitochondrial 3-oxoacyl-ACP synthase (OXSM) by hyperglycemia is associated with deficiency of alpha-lipoic acid synthetic pathway in kidney of diabetic mice.
    Biochem Biophys Res Commun. 2019 Mar 11. pii: S0006-291X(19)30370.
    PubMed     Text format     Abstract available


    BMJ

  7. IACOBUCCI G
    Sixty seconds on . . . reversing type 2 diabetes.
    BMJ. 2019;364:l1128.
    PubMed     Text format    


    Diabet Med

  8. CAREY ME, Agarwal S, Horne R, Davies M, et al
    Exploring organizational support for the provision of structured self-management education for people with Type 2 diabetes: findings from a qualitative study.
    Diabet Med. 2019 Mar 13. doi: 10.1111/dme.13946.
    PubMed     Text format     Abstract available


    Diabetes

  9. ZOBEL EH, Hasbak P, Winther SA, Stevns C, et al
    Cardiac Autonomic Function is Associated With Myocardial Flow Reserve in Type 1 Diabetes.
    Diabetes. 2019 Mar 12. pii: db18-1313. doi: 10.2337/db18-1313.
    PubMed     Text format     Abstract available

  10. DENHEZ B, Rousseau M, Dancosst DA, Lizotte F, et al
    Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Diabetes. 2019 Mar 12. pii: db18-0837. doi: 10.2337/db18-0837.
    PubMed     Text format     Abstract available


    Diabetes Care

  11. NIP ASY, Reboussin BA, Dabelea D, Bellatorre A, et al
    Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2019 Mar 12. pii: dc18-2420. doi: 10.2337/dc18-2420.
    PubMed     Text format     Abstract available

  12. KOZAWA J, Higashi M, Shimomura I, Hirano KI, et al
    Intractable Coronary Artery Disease in a Patient with Type 2 Diabetes Presenting With Triglyceride Deposit Cardiomyovasculopathy.
    Diabetes Care. 2019 Mar 12. pii: dc18-2365. doi: 10.2337/dc18-2365.
    PubMed     Text format    

  13. NEWMAN JD, Berger JS, Ladapo JA
    Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients With Diabetes.
    Diabetes Care. 2019 Mar 12. pii: dc18-1554. doi: 10.2337/dc18-1554.
    PubMed     Text format    

  14. HALDEN TAS, Kvitne KE, Midtvedt K, Rajakumar L, et al
    Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus.
    Diabetes Care. 2019 Mar 12. pii: dc19-0093. doi: 10.2337/dc19-0093.
    PubMed     Text format     Abstract available

  15. MONNETTE AM, Wharton MK, Zhao Y, Fonseca VA, et al
    Post-ACA Racial Disparity of Eye Examinations Among the U.S. Noninstitutionalized Population With Diabetes: 2014-2015.
    Diabetes Care. 2019 Mar 12. pii: dc18-1991. doi: 10.2337/dc18-1991.
    PubMed     Text format    

  16. YASSIN A, Haider A, Haider KS, Caliber M, et al
    Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
    Diabetes Care. 2019 Mar 12. pii: dc18-2388. doi: 10.2337/dc18-2388.
    PubMed     Text format     Abstract available

  17. SUBRAMANIAN A, Adderley NJ, Tracy A, Taverner T, et al
    Risk of Incident Obstructive Sleep Apnea Among Patients With Type 2 Diabetes.
    Diabetes Care. 2019 Mar 12. pii: dc18-2004. doi: 10.2337/dc18-2004.
    PubMed     Text format     Abstract available

  18. MCELFISH PA, Long CR, Kohler PO, Yeary KHK, et al
    Comparative Effectiveness and Maintenance of Diabetes Self-Management Education Interventions for Marshallese Patients With Type 2 Diabetes: A Randomized Controlled Trial.
    Diabetes Care. 2019 Mar 12. pii: dc18-1985. doi: 10.2337/dc18-1985.
    PubMed     Text format     Abstract available


  19. Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
    Diabetes Care. 2019 Mar 15. pii: dc18-1970. doi: 10.2337/dc18-1970.
    PubMed     Text format     Abstract available

  20. BEKKINK MO, Koeneman M, de Galan BE, Bredie SJ, et al
    Early Detection of Hypoglycemia in Type 1 Diabetes Using Heart Rate Variability Measured by a Wearable Device.
    Diabetes Care. 2019 Mar 15. pii: dc18-1843. doi: 10.2337/dc18-1843.
    PubMed     Text format     Abstract available


    Diabetes Educ

  21. LI H, Ji M, Scott P, Dunbar-Jacob JM, et al
    The Effect of Symptom Clusters on Quality of Life Among Patients With Type 2 Diabetes.
    Diabetes Educ. 2019 Mar 15:145721719837902. doi: 10.1177/0145721719837902.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  22. HEERSPINK HJL, List J, Perkovic V
    New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.
    Diabetes Obes Metab. 2018;20 Suppl 3:14-18.
    PubMed     Text format     Abstract available

  23. YANG W, Ma J, Hong T, Liu M, et al
    Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: a phase 3, open-label, 2:1 randomized, treat-to-target trial.
    Diabetes Obes Metab. 2019 Mar 14. doi: 10.1111/dom.13703.
    PubMed     Text format     Abstract available

  24. VERMA S, Bain SC, Monk Fries T, Mazer CD, et al
    Duration of Diabetes and Cardiorenal Efficacy of Liraglutide and Semaglutide: A Post Hoc Analysis of the LEADER and SUSTAIN 6 Clinical Trials.
    Diabetes Obes Metab. 2019 Mar 9. doi: 10.1111/dom.13698.
    PubMed     Text format     Abstract available

  25. RUSSELL-JONES D, Dauchy A, Delgado E, Dimitriadis G, et al
    Take Control: A Randomized Trial Evaluating the Efficacy and Safety of Self- Versus Physician-Managed Titration of Insulin Glargine 300 U/mL (Gla-300) in Patients with Uncontrolled Type 2 Diabetes.
    Diabetes Obes Metab. 2019 Mar 8. doi: 10.1111/dom.13697.
    PubMed     Text format     Abstract available

  26. PRATLEY RE, Emerson SS, Franek E, Gilbert MP, et al
    Cardiovascular safety and severe hypoglycaemia benefit of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: results from DEVOTE (DEVOTE 7).
    Diabetes Obes Metab. 2019 Mar 8. doi: 10.1111/dom.13699.
    PubMed     Text format     Abstract available

  27. CHEN Y, Yuan Z, Lu J, Eliaschewitz FG, et al
    Randomised study of Evolocumab in Patients With Type 2 Diabetes and Dyslipidaemia on Background Statin: Pre-Specified Analysis of the China Population From the BERSON Clinical Trial.
    Diabetes Obes Metab. 2019 Mar 9. doi: 10.1111/dom.13700.
    PubMed     Text format     Abstract available


    Diabetologia

  28. GURLO T, Kim S, Butler AE, Liu C, et al
    Pregnancy in human IAPP transgenic mice recapitulates beta cell stress in type 2 diabetes.
    Diabetologia. 2019 Mar 9. pii: 10.1007/s00125-019-4843.
    PubMed     Text format     Abstract available

  29. MATTHEWS DR, Li Q, Perkovic V, Mahaffey KW, et al
    Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.
    Diabetologia. 2019 Mar 12. pii: 10.1007/s00125-019-4839.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  30. CARLSTROM M
    The Other Glucose Transporter, SGLT1 - Also a Potential Trouble Maker in Diabetes?
    J Am Soc Nephrol. 2019 Mar 13. pii: ASN.2019020171. doi: 10.1681/ASN.2019020171.
    PubMed     Text format    

  31. HONG Q, Zhang L, Fu J, Verghese DA, et al
    LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-beta-Induced Angiogenesis.
    J Am Soc Nephrol. 2019 Mar 11. pii: ASN.2018060599. doi: 10.1681/ASN.2018060599.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  32. MORENO RC, Navas-Acien A, Escolar E, Nathan DM, et al
    Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 14. pii: 5376633. doi: 10.1210/jc.2018-01484.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  33. WANG D, Wang H, Liu C, Mu X, et al
    Hyperglycemia inhibition of endothelial miR-140-3p mediates angiogenic dysfunction in diabetes mellitus.
    J Diabetes Complications. 2019 Feb 10. pii: S1056-8727(18)30962.
    PubMed     Text format     Abstract available

  34. ZENG JB, Liu HB, Ping F, Li W, et al
    Insulin treatment affects leukocyte telomere length in patients with type 2 diabetes: 6-year longitudinal study.
    J Diabetes Complications. 2019 Feb 12. pii: S1056-8727(18)31308.
    PubMed     Text format     Abstract available


    JAMA

  35. GLASSMAN AR
    Errors in Analysis of Mean Deviations in Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1007-1008.
    PubMed     Text format    

  36. ABBASI J
    Quick Uptakes: After Rotavirus Vaccine, Australia's Type 1 Diabetes Incidence Declines.
    JAMA. 2019 Mar 13. pii: 2728577. doi: 10.1001/jama.2019.0766.
    PubMed     Text format    


  37. Errors in Analysis of Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1008.
    PubMed     Text format    


    Lancet

  38. COSTACOU T, Guo J, Miller RG, Orchard TJ, et al
    Excess mortality and cardiovascular disease risk in type 1 diabetes.
    Lancet. 2019;393:985.
    PubMed     Text format    

  39. XIAO F, Liu M, Wang XF
    Involuntary choreiform movements in a diabetic patient.
    Lancet. 2019;393:1033.
    PubMed     Text format    

  40. SNAITH JR, Holmes-Walker DJ, Girgis CM, Greenfield JR, et al
    Excess mortality and cardiovascular disease risk in type 1 diabetes.
    Lancet. 2019;393:984-985.
    PubMed     Text format    

  41. RAWSHANI A, Sattar N, Franzen S, Rawshani A, et al
    Excess mortality and cardiovascular disease risk in type 1 diabetes - Authors' reply.
    Lancet. 2019;393:985-986.
    PubMed     Text format    


    Lancet Diabetes Endocrinol


  42. Correction to Lancet Diabetes Endocrinol 2019; published online March 1. DOI:10.1016/ S2213-8587(19)30066-X.
    Lancet Diabetes Endocrinol. 2019 Mar 11. pii: S2213-8587(19)30109.
    PubMed     Text format    

  43. THE LANCET DIABETES ENDOCRINOL
    Towards gender equity in diabetes and endocrinology.
    Lancet Diabetes Endocrinol. 2019 Mar 7. pii: S2213-8587(19)30090.
    PubMed     Text format    


  44. Correction to Lancet Diabetes Endocrinol 2019; 7: https://doi.org/10.1016/S2213-8587(18)30339-5.
    Lancet Diabetes Endocrinol. 2019 Mar 7. pii: S2213-8587(19)30095.
    PubMed     Text format    

  45. LEAN MEJ, Leslie WS, Barnes AC, Brosnahan N, et al
    Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
    Lancet Diabetes Endocrinol. 2019 Mar 5. pii: S2213-8587(19)30068.
    PubMed     Text format     Abstract available

  46. MORRIS E, Jebb S, Aveyard P
    Type 2 diabetes: treating not managing.
    Lancet Diabetes Endocrinol. 2019 Mar 5. pii: S2213-8587(19)30071.
    PubMed     Text format    


    Metabolism

  47. KOOPMAN ADM, Beulens JW, Voerman E, Rauh SP, et al
    GAD65 antibodies and incident type 2 Diabetes mellitus.
    Metabolism. 2019 Mar 7. pii: S0026-0495(19)30049.
    PubMed     Text format     Abstract available


    Nutr Metab (Lond)

  48. LIN X, Yang Y, Qu J, Wang X, et al
    Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARgamma.
    Nutr Metab (Lond). 2019;16:17.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  49. BALAMURUGAN K, Kavitha B, Yang Z, Mohan V, et al
    Functional characterization of activating mutations in the SUR1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
    Pediatr Diabetes. 2019 Mar 12. doi: 10.1111/pedi.12843.
    PubMed     Text format     Abstract available

  50. CHEN Y, Wang T, Liu X, Shankar RR, et al
    Prevalence of Type 1 and Type 2 Diabetes among US Pediatric Population in the MarketScan Multi-State Medicaid Database, 2002-2016.
    Pediatr Diabetes. 2019 Mar 12. doi: 10.1111/pedi.12842.
    PubMed     Text format     Abstract available

  51. CHOPRA A, Sudhanshu S, Chen Y, Mangla P, et al
    The impact of free medical supplies and regular telephonic contact on glycemic control in Indian children and adolescents with type 1 diabetes.
    Pediatr Diabetes. 2019 Mar 12. doi: 10.1111/pedi.12844.
    PubMed     Text format     Abstract available


    PLoS One

  52. DEKKER R, Hristova YV, Hijmans JM, Geertzen JHB, et al
    Pre-operative rehabilitation for dysvascular lower-limb amputee patients: A focus group study involving medical professionals.
    PLoS One. 2018;13:e0204726.
    PubMed     Text format     Abstract available

  53. SILZER T, Barber R, Sun J, Pathak G, et al
    Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans.
    PLoS One. 2019;14:e0213527.
    PubMed     Text format     Abstract available

  54. LUND A, Ebbing C, Rasmussen S, Kiserud T, et al
    Altered development of fetal liver perfusion in pregnancies with pregestational diabetes.
    PLoS One. 2019;14:e0211788.
    PubMed     Text format     Abstract available

  55. STEVENS M, Neal CR, Craciun EC, Dronca M, et al
    The natural drug DIAVIT is protective in a type II mouse model of diabetic nephropathy.
    PLoS One. 2019;14:e0212910.
    PubMed     Text format     Abstract available

  56. LEE CK, Choi SK, Shin DA, Yi S, et al
    Influence of diabetes mellitus on patients with lumbar spinal stenosis: A nationwide population-based study.
    PLoS One. 2019;14:e0213858.
    PubMed     Text format     Abstract available

  57. MIRAGLIA JL, Cintra Nunes Mafra AC, Nascimento Monteiro C, Morais Borges L, et al
    The variation of the burden of hypertension and diabetes in two large districts of the city of Sao Paulo, Brazil, based on primary health care routinely-collected data.
    PLoS One. 2019;14:e0213998.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: